Olema Pharmaceuticals Inc (OLMA) Stock Analysis

Olema Pharmaceuticals Inc (OLMA) is a publicly traded company in the HEALTHCARE sector. It trades at $10.69, carries a market capitalization of $1.15B. This page summarizes the public market data, fundamentals, and frequently asked questions for OLMA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Olema Pharmaceuticals Inc currently has a Neutral sentiment score of 0.11.

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of targeted therapies for women's cancers. With a commitment to addressing substantial unmet medical needs in a historically underrepresented patient demographic, Olema is advancing an innovative pipeline of novel compounds aimed at improving patient outcomes. The company is strategically positioned within the oncology sector as it pro...

GNG Research Analysis

GNG Research scores Olema Pharmaceuticals Inc (OLMA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OLMA.

Frequently Asked Questions

Does OLMA pay dividends?

Olema Pharmaceuticals Inc (OLMA) does not currently pay a regular dividend.

What is OLMA's market cap?

Olema Pharmaceuticals Inc (OLMA) has a market capitalization of $1.15B with a current stock price of $10.69.